Cwm LLC Acquires 9,165 Shares of Bruker Co. (NASDAQ:BRKR)

Cwm LLC raised its holdings in Bruker Co. (NASDAQ:BRKR) by 191.9% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 13,942 shares of the medical research company’s stock after acquiring an additional 9,165 shares during the quarter. Cwm LLC’s holdings in Bruker were worth $963,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of BRKR. First Horizon Advisors Inc. increased its stake in Bruker by 120.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 399 shares of the medical research company’s stock worth $25,000 after buying an additional 218 shares during the period. Rise Advisors LLC purchased a new position in shares of Bruker during the first quarter worth approximately $27,000. Covestor Ltd raised its stake in shares of Bruker by 139.1% during the first quarter. Covestor Ltd now owns 361 shares of the medical research company’s stock valued at $34,000 after acquiring an additional 210 shares in the last quarter. Gordian Capital Singapore Pte Ltd purchased a new stake in shares of Bruker in the second quarter valued at approximately $52,000. Finally, GAMMA Investing LLC grew its stake in Bruker by 81.0% in the third quarter. GAMMA Investing LLC now owns 867 shares of the medical research company’s stock worth $60,000 after purchasing an additional 388 shares in the last quarter. Hedge funds and other institutional investors own 79.52% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on BRKR shares. TD Cowen decreased their target price on Bruker from $74.00 to $72.00 and set a “hold” rating for the company in a research report on Wednesday, August 7th. Citigroup lowered their price objective on shares of Bruker from $95.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, July 10th. Barclays assumed coverage on shares of Bruker in a report on Tuesday. They issued an “overweight” rating and a $75.00 price target for the company. The Goldman Sachs Group dropped their price objective on shares of Bruker from $72.00 to $60.00 and set a “sell” rating on the stock in a research note on Tuesday, July 9th. Finally, Wolfe Research downgraded shares of Bruker from an “outperform” rating to a “peer perform” rating in a research note on Monday, September 30th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, Bruker currently has a consensus rating of “Moderate Buy” and a consensus price target of $80.82.

Bruker Trading Down 1.3 %

NASDAQ BRKR opened at $60.49 on Friday. The stock has a market cap of $8.79 billion, a P/E ratio of 22.00, a P/E/G ratio of 2.52 and a beta of 1.18. The company has a current ratio of 1.65, a quick ratio of 0.75 and a debt-to-equity ratio of 1.18. The company has a fifty day simple moving average of $65.09 and a two-hundred day simple moving average of $69.37. Bruker Co. has a 12-month low of $53.79 and a 12-month high of $94.86.

Bruker (NASDAQ:BRKR) last posted its quarterly earnings results on Tuesday, August 6th. The medical research company reported $0.52 earnings per share for the quarter, meeting the consensus estimate of $0.52. Bruker had a return on equity of 24.92% and a net margin of 11.29%. The business had revenue of $800.70 million for the quarter, compared to the consensus estimate of $799.44 million. During the same quarter in the previous year, the business earned $0.50 EPS. The company’s quarterly revenue was up 17.4% compared to the same quarter last year. On average, analysts forecast that Bruker Co. will post 2.61 earnings per share for the current year.

Bruker Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Shareholders of record on Monday, September 2nd were paid a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.33%. The ex-dividend date was Friday, August 30th. Bruker’s payout ratio is 7.27%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.